Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome

AIDS

Volumn 18, Issue 17, 2004, Pages 2285-2293

  Puoti, Massimo ^a   Bruno, Raffaele ^b,c   Soriano, Vincent ^d   Donato, Francesco ^a   Gaeta, Giovanni Battista ^e   Quinzan, Gian Paolo ^f   Precone, Davide ^g,h   Gelatti, Umberto ^a   Asensi, Victor ^g,h   Vaccher, Emanuela ⁱ  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Ist di Clin delle Malat Infettive   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g Hospital General   (Spain)

^h CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

ⁱ CRO Aviano ^*

Author keywords

Alcohol; Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; HIV

Indexed keywords

ADULT; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LIVER CELL CARCINOMA; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 10244234049     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200411190-00009     Document Type: Article

References (37)

1. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003, 38(suppl):136-149.
2. Bonacini M, Puoti M. Hepatitis in patients with HIV infection: diagnosis, natural history and meta-analysis of sexual and vertical transmission. Arch Int Med 2000, 160:3365-3373.
3. Fultz S, Justice A, Butt A, Rabeneck L, Weissman S, Rodriguez-Barradas M. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with HIV infection. Clin Infect Dis 2003, 36:1039-1046.
4. Buffet-Janvresse C, Peigue-Lafeuille H, Benichou J, Vabret A, Branger M, Timoulet P, et al. HIV and HCV co-infection: Situation at six French university hospitals in the year 2000. J Med Virol 2003, 69:7-17.
5. Thomas D. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002, 36(suppl):201-209.
6. Solomon R, Van Raden M, Kaslow R, Lyter D, Visscher B, Farzadegan H, Phair J. Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of the acquired immunodeficiency syndrome. Am J Pub Health 1990, 80:1475-1478.
7. Lee W. Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
8. Thio C, Seaberg E, Skolasky R, Phair J, Visscher B, Munoz A, Thomas DL. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002, 360:1921-1926.
9. Vogel J, Hinrichs S, Napolitano L, Ngo L, Jay C. Liver cancer in transgenic mice carrying the HIV tat gene. Cancer Res 1991, 51:6686-6690.
10. Corallini A, Altavilla G, Pozzi L, Bignozzi F, Negrini M, Rimessi P, et al. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993; 53:5569-5575.
11. Altavilla G, Caputo A, Lanfredi M, Piola C, Barbanti-Brodano G, Corallini A. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 2000, 157:1081-1089.
12. Barak O, Aronheim A, Shaul Y. HBV X protein targets HIV Tat-binding protein 1. Virology 2001, 283:110-120.
13. Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000, 14:553-559.
14. Rosenthal E, Poiree M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003, 17:1803-1809.
15. Garcia-Samaniego J, Rodriguez M, Berenguer J, Carbo J, Asensi V, Soriano V. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001, 96:179-183.
16. Viriyavejakul P, Rojanasunan P, Viriyavejakul A, Punyarit P, Punpoowong B, Khachansaksumet V, et al. Opportunistic infections in the liver of HIV-infected patients in Thailand: a necropsy study. Southeast Asian J Trop Med Public Health 2000, 31:663-667.
17. Trojan A, Kreuzer KA, Flury R, Schmid M, Schneider J, Schroder S. Liver changes in AIDS. Retrospective analysis of 227 autopsies of HIV-positive patients. Pathologe 1998, 19:194-200.
18. Tradati F, Colombo M, Mannucci P, Rumi M, De Fazio C, Gamba G, et al. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998, 91:1173-1177.
19. Weinig M, Hakim J, Gudza I, Tobaiwa O. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study. Trans R Soc Trop Med Hyg 1997, 91:570-572.
20. Darby S, Ewart D, Giangrande P, Spooner R, Rizza C, Dusheiko G, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997, 350:1425-1431.
21. Tanaka T, Imamura A, Masuda G, Ajisawa A, Negishi M, Tanaka S, et al. A case of hepatocellular carcinoma in HIV-infected patient. Hepatogastroenterology 1996, 43:1067-1072.
22. Bruno R, Sacchi P, Filice C, Puoti M, Filice G. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. J Acquir Immune Defic Syndr 2002, 30:535-536.
23. Viriyavejakul P, Tangwanicharoen T, Rojanasunan P, Khachansaksumet V. Does HIV infection accelerates the development of hepatocellular carcinoma? A case report in a young man. Southeast Asian J Trop Med Public Health 2001, 32:504-506.
24. Monfardini S, Vaccher E, Foà R, Tirelli U. AIDS associated non-Hodgkin lymphoma in Italy: intravenous drugs users vs. homosexual men. Ann Oncol 1990, 1:203-211.
25. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Christensen E, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001, 35:421-430.
26. Donato F, Tagger A, Chiesa R, Ribero M, Tomasoni V, Fasola M, et al. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma; a case-control study in Italy. Hepatology 1997, 26:579-585.
27. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, et al. Case control study of HCV as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer 1999, 81:695-699.
28. Gelatti U, Donato F, Tagger A, Fantoni C, Portolani N, Ribero ML, et al. Etiology of hepatocellular carcinoma influences clinical and pathological features but not patients survival. Am J Gastroenterol 2003, 98:907-914.
29. The Cancer of the Liver Italian Project (CLIP). A new prognostic system for Hepatocellular Carcinoma: A retrospective study of 435 patients. Hepatology 1998, 28:751-755.
30. CLIP. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000, 31:840-845.
31. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd Edn. Oxford: Blackwell Scientific Publications, 1994.
32. El-Serag H, Davila J, Petersen N, McGlynn K. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817-823.
33. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1914.
34. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxì A, Chiaramonte M, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998, 29:944-952.
35. Raptis I, Koskinas J, Emanouil T, Hadziyannis S. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations. J Viral Hepat 2003, 10:450-454.
36. Seef L. Natural history of chronic hepatitis C. Hepatology 2002, 36(suppl):35-46.
37. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998, 75:347-354.